Hologic Device Approved by FDA

Xconomy Boston — 

Bedford, MA-based Hologic (NASDAQ: HOLX) announced that the FDA has approved its permanent contraception device, called Adiana. Offering a less-invasive alternative to tubal ligation—a surgical procedure that is one of the most common forms of contraception worldwide—the device can be inserted via catheter through the vagina in a 15-minute procedure. Hologic gained European approval for the device this past January.